How to manage candida auris infection?

Question

Hello doctor,

My aunt is in the ICU with Candida auris, and we are all very worried. She has diabetes and was recovering from a recent surgery when she suddenly became confused and weak. Now, the doctors say this fungus is in her bloodstream and is very hard to treat. We had never even heard of it before, and reading about it online has just scared us more. We’re hoping she can recover, but things look serious. Please tell me what families should realistically expect.

Is this something that happens often in hospitals?
Can it be spread between patients? And what treatments are there?

Kindly help.

Answer 1

Hello,

Welcome to icliniq.com.

I read your query and can understand your concern.

Candida auris is a serious and emerging fungal infection, particularly affecting critically ill or immunocompromised patients. You are not alone in finding it unfamiliar; it is a relatively new pathogen first identified in 2009, but it has become a growing concern globally, especially in hospital settings.

Why it is serious: Candida auris can enter the bloodstream and cause severe, systemic infections (candidemia), especially in ICU patients with central lines, catheters, weakened immunity (like diabetes), or recent surgeries. It’s also known for its ability to resist common antifungal medications, making treatment more challenging.
How it spreads: Yes, unfortunately, it can spread between patients, particularly through contact with contaminated surfaces or healthcare equipment. This is why hospitals follow strict isolation protocols, requiring protective gowns, gloves, and masks for anyone entering the room, this helps protect other patients and staff.
Treatment: Treatment generally includes Echinocandin antifungal medications such as Micafungin, Caspofungin, or Anidulafungin. In instances of severe or resistant infections, combination therapy or newer antifungal agents like Liposomal Amphotericin B may be employed. Management includes:

Eliminating infected lines or catheters.
Managing underlying conditions such as diabetes.
Observing for organ dysfunction or sepsis.

Differential diagnosis: Bacterial sepsis, other Candida species infection, drug-induced fever, invasive fungal infections (Aspergillosis, Cryptococcosis)
Regarding follow-up: Repeat cultures to confirm clearance. Follow up with infectious disease and endocrinology teams. Monitor for long-term complications if she recovers. Screen close ICU contacts if deemed necessary by infection control
Preventive measures: Strict contact precautions in ICU, Terminal cleaning of ICU room with sporicidal agents, Hand hygiene and barrier precautions for staff and visitors, Monitoring other ICU patients for colonization.

The likelihood of recovery is influenced by various factors, including the severity of the infection (particularly if it has entered the bloodstream), the effectiveness of antifungal treatment, pre-existing health issues (such as diabetes, kidney disorders, and immune system suppression), and the success of infection control strategies.

Although severe cases, particularly in intensive care units, can lead to high mortality rates, there are instances where patients do recover, particularly when diagnosed early and treated vigorously. This is understandably a frightening time. Focus on open communication with the ICU and infectious disease teams. Ask about your aunt's response to antifungals, lab trends, and if other interventions (like source control or line removal) are planned. Please do not lose hope. Advances in ICU care and infection control have improved outcomes even in tough infections like this one.

I hope this information helps you.

Feel free to ask further queries.